We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies.

X

Sources

1Intradermal delivery of vaccines: potential benefits and current challenges, January 2011 http://www.who.int/bulletin/volumes/89/3/10-079426

Intradermal vaccination using the novel microneedle device MicronJet600: Past, present, and future. Human Vaccines & Immunotherapeutics 11:4, 991–997; April 2015; http://www.tandfonline.com/doi/full/10.1080/21645515.2015.1010871

2A phase 1, open-label, randomized study to compare the immunogenicity and safety of different administration routes and doses of virosomal influenza vaccine in elderly. http://www.sciencedirect.com/science/article/pii/S0264410X16308040

Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial. Vaccine 33 (2015) 6816–6822. http://www.sciencedirect.com/science/article/pii/S0264410X15013158

Previous Next
Doug Hostetler

Doug Hostetler

Principle SME, Admin. Systems, TCS

Subscribe to receive the latest blog post